Free Trial

Kenvue Q3 2023 Earnings Report

Kenvue logo
$21.77 +0.16 (+0.74%)
(As of 12/20/2024 05:40 PM ET)

Kenvue EPS Results

Actual EPS
$0.31
Consensus EPS
$0.30
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Kenvue Revenue Results

Actual Revenue
$3.92 billion
Expected Revenue
$3.87 billion
Beat/Miss
Beat by +$44.56 million
YoY Revenue Growth
N/A

Kenvue Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

Kenvue Earnings Headlines

Kenvue Inc. stock rises Thursday, outperforms market
Kenvue Inc. stock rises Friday, still underperforms market
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Barclays Upgrades Kenvue (NYSE:KVUE) to "Hold"
See More Kenvue Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kenvue? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kenvue and other key companies, straight to your email.

About Kenvue

Kenvue (NYSE:KVUE) operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

View Kenvue Profile

More Earnings Resources from MarketBeat

Upcoming Earnings